금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
Dow Jones futures slip on hawkish sentiment surrounding Fed outlook
Dow Jones futures fall by 0.13%, trading near 52,000 during the European hours on Wednesday. However...
Euro extends downfall against US Dollar amid firm Fed hike bets
The Euro (EUR) extends its losing streak against the US Dollar (USD) for the third trading day on We...
Buckle Up! Fed Chair Kevin Warsh's 10-Word Statement on Inflation Implies That Wall Street Will Be Forced to Take Its Medicine.
A three-year high for inflation may force the Federal Open Market Committee (FOMC) into action....
IBM Is Defying Tuesday's Tech Rout. Here's Why the Stock Is Surging
IBM shares gained Tuesday, bucking the trend as the broader tech sector came under pressure.
‘Decent chance’ the Fed will raise interest rates in July – Goldman Sachs’ Rosner
Qualcomm Stock Falls Sharply but the Chip Maker Has a Plan to Save AI Rally
Qualcomm stock has surged in recent months and the prospective acquisition of an AI infrastructure software company could help keep the rally going.
Biotech breakout: iShares Biotechnology ETF hits all-time high
TechnipFMC to supply flexible pipes for Azule Energy’s Greater PAJ project
Convenience store operator EG Group files confidentially for $1B IPO
Is Roundhill Generative AI ETF or iShares U.S. Tech ETF Better In a Volatile Market?
Compare portfolio concentration, sector focus, and income potential as these two tech ETFs take different paths to growth.
Tesla Stock’s Good News on Sales Overwhelmed by the Bad
Tesla stock slipped as the National Highway Traffic Safety Administration said it would examine a fatal crash.
Nasdaq Riding Most Volatile Stretch Since 2024
The Nasdaq Composite hasn't had a stretch this volatile in nearly two years. If the Nasdaq moves more than 1% today, it would mark its longest such stretch of two-way volatility since Aug. 8, 2024, a ...
SpaceX is said to draw huge demand for first bond sale
Facing activist pressure, SPS Commerce exploring a sale — Reuters
Regeneron myasthenia gravis therapy undergoes U.S. and EU review